A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated® human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease
2007 ◽
Vol 39
(1)
◽
pp. 115-118
◽
2010 ◽
Vol 99
(2)
◽
pp. S40-S41
◽
2002 ◽
Vol 113
(2)
◽
pp. 112-119
◽
2010 ◽
Vol 85
(11)
◽
pp. 908-909
◽
2014 ◽
Vol 9
(1)
◽
pp. 51
◽
2018 ◽
Vol 68
◽
pp. 211-217
◽